148 related articles for article (PubMed ID: 37141667)
1. The TFDP1 gene coding for DP1, the heterodimeric partner of the transcription factor E2F, is a target of deregulated E2F.
Nakajima R; Deguchi R; Komori H; Zhao L; Zhou Y; Shirasawa M; Angelina A; Goto Y; Tohjo F; Nakahashi K; Nakata K; Iwanaga R; Bradford AP; Araki K; Warita T; Ohtani K
Biochem Biophys Res Commun; 2023 Jun; 663():154-162. PubMed ID: 37141667
[TBL] [Abstract][Full Text] [Related]
2. Differential requirement for dimerization partner DP between E2F-dependent activation of tumor suppressor and growth-related genes.
Komori H; Goto Y; Kurayoshi K; Ozono E; Iwanaga R; Bradford AP; Araki K; Ohtani K
Sci Rep; 2018 May; 8(1):8438. PubMed ID: 29855511
[TBL] [Abstract][Full Text] [Related]
3. Deregulated E2F Activity as a Cancer-Cell Specific Therapeutic Tool.
Nakajima R; Zhao L; Zhou Y; Shirasawa M; Uchida A; Murakawa H; Fikriyanti M; Iwanaga R; Bradford AP; Araki K; Warita T; Ohtani K
Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833320
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor TAp73 gene specifically responds to deregulated E2F activity in human normal fibroblasts.
Ozono E; Komori H; Iwanaga R; Tanaka T; Sakae T; Kitamura H; Yamaoka S; Ohtani K
Genes Cells; 2012 Aug; 17(8):660-72. PubMed ID: 22702391
[TBL] [Abstract][Full Text] [Related]
5. E2F1 and TFDP1 Regulate PITX1 Expression in Normal and Osteoarthritic Articular Chondrocytes.
Pellicelli M; Picard C; Wang D; Lavigne P; Moreau A
PLoS One; 2016; 11(11):e0165951. PubMed ID: 27802335
[TBL] [Abstract][Full Text] [Related]
6. Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression.
Lukas J; Petersen BO; Holm K; Bartek J; Helin K
Mol Cell Biol; 1996 Mar; 16(3):1047-57. PubMed ID: 8622649
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel target genes specifically activated by deregulated E2F in human normal fibroblasts.
Kitamura H; Ozono E; Iwanaga R; Bradford AP; Okuno J; Shimizu E; Kurayoshi K; Kugawa K; Toh H; Ohtani K
Genes Cells; 2015 Sep; 20(9):739-57. PubMed ID: 26201719
[TBL] [Abstract][Full Text] [Related]
8. Cancer cell specific cytotoxic gene expression mediated by ARF tumor suppressor promoter constructs.
Kurayoshi K; Ozono E; Iwanaga R; Bradford AP; Komori H; Ohtani K
Biochem Biophys Res Commun; 2014 Jul; 450(1):240-6. PubMed ID: 24893334
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of E2F1, DP1, and the E2F1/DP1 complex by ARF.
Datta A; Nag A; Raychaudhuri P
Mol Cell Biol; 2002 Dec; 22(24):8398-408. PubMed ID: 12446760
[TBL] [Abstract][Full Text] [Related]
10. ARF directly binds DP1: interaction with DP1 coincides with the G1 arrest function of ARF.
Datta A; Sen J; Hagen J; Korgaonkar CK; Caffrey M; Quelle DE; Hughes DE; Ackerson TJ; Costa RH; Raychaudhuri P
Mol Cell Biol; 2005 Sep; 25(18):8024-36. PubMed ID: 16135794
[TBL] [Abstract][Full Text] [Related]
11. E2F-like elements in p27(Kip1) promoter specifically sense deregulated E2F activity.
Ozono E; Komori H; Iwanaga R; Ikeda MA; Iseki S; Ohtani K
Genes Cells; 2009 Jan; 14(1):89-99. PubMed ID: 19077036
[TBL] [Abstract][Full Text] [Related]
12. Ectopic expression of the CDK inhibitor p21
Kurayoshi K; Shiromoto A; Ozono E; Iwanaga R; Bradford AP; Araki K; Ohtani K
Biochem Biophys Res Commun; 2017 Jan; 483(1):107-114. PubMed ID: 28042030
[TBL] [Abstract][Full Text] [Related]
13. Unique roles for E2F1 in the mouse lens in the absence of functional pRB proteins.
Hyde RK; Griep AE
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1509-16. PubMed ID: 11980867
[TBL] [Abstract][Full Text] [Related]
14. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
[TBL] [Abstract][Full Text] [Related]
15. Deregulated E2F transcriptional activity in autonomously growing melanoma cells.
Halaban R; Cheng E; Smicun Y; Germino J
J Exp Med; 2000 Mar; 191(6):1005-16. PubMed ID: 10727462
[TBL] [Abstract][Full Text] [Related]
16. COMMD9 promotes TFDP1/E2F1 transcriptional activity via interaction with TFDP1 in non-small cell lung cancer.
Zhan W; Wang W; Han T; Xie C; Zhang T; Gan M; Wang JB
Cell Signal; 2017 Jan; 30():59-66. PubMed ID: 27871936
[TBL] [Abstract][Full Text] [Related]
17. E2F as a regulator of keratinocyte proliferation: implications for skin tumor development.
Jones SJ; Dicker AJ; Dahler AL; Saunders NA
J Invest Dermatol; 1997 Aug; 109(2):187-93. PubMed ID: 9242506
[TBL] [Abstract][Full Text] [Related]
18. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release.
Rubin SM; Gall AL; Zheng N; Pavletich NP
Cell; 2005 Dec; 123(6):1093-106. PubMed ID: 16360038
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the Chlamydomonas cell cycle by a stable, chromatin-associated retinoblastoma tumor suppressor complex.
Olson BJ; Oberholzer M; Li Y; Zones JM; Kohli HS; Bisova K; Fang SC; Meisenhelder J; Hunter T; Umen JG
Plant Cell; 2010 Oct; 22(10):3331-47. PubMed ID: 20978220
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the Arf/p53 tumor surveillance network by E2F.
Iaquinta PJ; Aslanian A; Lees JA
Cold Spring Harb Symp Quant Biol; 2005; 70():309-16. PubMed ID: 16869767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
